Fibrous nano-silica sphere (KCC-1) has appeared as a good and efficient catalyst for ultrasonic irradiation conditions in chemical reactions. This catalyst has the unique properties such as a fibrous surface morphology, high surface area and high mechanical stability. The results indicated that the KCC-1 nanocatalyst could be used as high-performance catalysts under high temperature and pressure condition in organic reaction under ultrasonic irradiation. Morphology, structure, and composition of the fibrous nano-silica sphere were described by N2 adsorption–desorption analysis, scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA) and Fourier-transform infrared spectroscopy (FT-IR). In this work, we used KCC-1@NH2 nanosilica as a basic catalyst for the preparation of chromenes under ultrasonic irradiation conditions for the first time. The recyclability, nontoxicity and high stability of the catalyst, combined with low reaction times and excellent yields, make the present protocol very useful for the synthesis of the title products under ultrasonic conditions. The produced products were confirmed via 1H NMR, 13C NMR, FT-IR analysis.
In this study, morpholine sulfate acidic ionic liquid bonded on magnetite nanoparticles (Mag@Morph-AIL) has been used as a catalyst for the preparation of 3,4-dihydropyrimidinones.
l-Tryptophan functionalized silica-coated magnetic nanoparticles were prepared and evaluated as a magnetic nanocatalyst for the synthesis of spiro[indene-2,2′-naphthalene]-4′-carbonitrile derivatives through the one-pot four-component reaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.